Preliminary experience with the use of transcatheter aortic valve implantation (TAVI) to treat non-calcific aortic regurgitation has raised concerns about the short-term effectiveness of TAVI in this setting. A deeper understanding of the interaction between transcatheter heart valves and anatomy in patients with non-calcific aortic valve disease, coupled with the introduction of dedicated TAVI devices, is providing new opportunities in the management of this condition.
Transcatheter treatment of pure aortic regurgitation / Barbanti, M., Laterra, G., Maisano, F.. - In: NATURE REVIEWS. CARDIOLOGY. - ISSN 1759-5002. - 21:9(2024), pp. 597-598. [10.1038/s41569-024-01059-1]
Transcatheter treatment of pure aortic regurgitation
Maisano F.Ultimo
2024-01-01
Abstract
Preliminary experience with the use of transcatheter aortic valve implantation (TAVI) to treat non-calcific aortic regurgitation has raised concerns about the short-term effectiveness of TAVI in this setting. A deeper understanding of the interaction between transcatheter heart valves and anatomy in patients with non-calcific aortic valve disease, coupled with the introduction of dedicated TAVI devices, is providing new opportunities in the management of this condition.| File | Dimensione | Formato | |
|---|---|---|---|
|
s41569-024-01059-1.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Tutti i diritti riservati
Dimensione
701.48 kB
Formato
Adobe PDF
|
701.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
